Revolution Medicines, Inc 10-K for FY2023
Revolution Medicines, Inc. (RVMD)
10-K
2024-02-26
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 10-K
Revolution Medicines, Inc filed this 10-K on February 26, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $11.58M
- down 67.3% from $35.38M a year earlier
- Net loss
- $436.37M
- compared with a net loss of $248.71M a year earlier
- Diluted EPS
- -$3.86
- compared with -$3.08 a year earlier